Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 170 Neoplasm Metastasis 139 Neoplasms 136 Leukemia, Myeloid, Acute 133 Colorectal Neoplasms 115 Breast Neoplasms 115 Melanoma 90 Ovarian Neoplasms 88 Prostatic Neoplasms 85 Recurrence 83 Multiple Myeloma 81 Lung Neoplasms 73 Squamous Cell Carcinoma of Head and Neck 72 Glioblastoma 71 Pancreatic Neoplasms 70 Myelodysplastic Syndromes 63 Lymphoma, Non-Hodgkin 59 Triple Negative Breast Neoplasms 53 Glioma 53 Stomach Neoplasms 49 Endometrial Neoplasms 46 Brain Neoplasms 46 Precursor Cell Lymphoblastic Leukemia-Lymphoma 45 Lymphoma, Large B-Cell, Diffuse 45 Carcinoma, Renal Cell 45 Small Cell Lung Carcinoma 44 Lymphoma, Follicular 40 Lymphoma, B-Cell 40 Carcinoma, Hepatocellular 40 Sarcoma 39

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × mCRC × 90 days × Clear all

NCT07543471 2026-04-24

PK similarity

Shanghai Henlius Biotech

Phase 1 Not yet recruiting

mCRC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡